tragacanth supplementation and type 2 diabetes - Trial IRCT20150205020965N6
Access comprehensive clinical trial information for IRCT20150205020965N6 through Pure Global AI's free database. This Phase 2 trial is sponsored by Tabriz University of Medical Sciences and is currently Completed. The study focuses on Type 2 Diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20150205020965N6
Phase 2
Completed
biological
Trial Details
Iranian Registry Of Clinical Trial • IRCT20150205020965N6
tragacanth supplementation and type 2 diabetes
The effect of tragacanth supplementation on the status of metabolic, inflammatory parameters and mental health in women with type 2 diabetes
Study Focus
Sponsor & Location
Tabriz University of Medical Sciences
Iran
Timeline & Enrollment
Phase 2
Nov 21, 2020
N/A
ICD-10 Classifications
Type 2 diabetes mellitus
Type 2 diabetes mellitus with unspecified complications
Type 2 diabetes mellitus with other specified complications
Type 2 diabetes mellitus without complications
Type 2 diabetes mellitus with multiple complications
Data Source
Iranian Registry Of Clinical Trial
IRCT20150205020965N6
Non-Device Trial